Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2010, Article ID 938640, 7 pages
http://dx.doi.org/10.1155/2010/938640
Review Article

饾浗 -Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload

Weill Cornell Medical College, Department of Pediatrics, Division of Hematology-Oncology, 515E 71st street, S702, New York, NY 10021, USA

Received 25 November 2009; Accepted 28 February 2010

Academic Editor: Elizabeta Nemeth

Copyright © 2010 Luca Melchiori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [37 citations]

The following is the list of published articles that have cited the current article.

  • Stefano Rivella, Elizabeta Nemeth, and Jeffery Lynn Miller, “Crosstalk between Erythropoiesis and Iron Metabolism,” Advances in Hematology, vol. 2010, pp. 1–2, 2010. View at PublisherView at Google Scholar
  • Yelena Ginzburg, and Stefano Rivella, “beta-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism,” Blood, vol. 118, no. 16, pp. 4321–4330, 2011. View at PublisherView at Google Scholar
  • I.F. Estevão, P. Peitl Junior, and C.R. Bonini-Domingos, “Serum ferritin and transferrin saturation levels in β0 and β+ thalassemia patients,” Genetics and Molecular Research, vol. 10, no. 2, pp. 632–639, 2011. View at PublisherView at Google Scholar
  • Robert Moreau, Erin Lynn Dodd, David Scott Bohle, Tatiana Scorza, Diane Tshikudi Malu, Mathieu Dumais, Esther Dalko, Véronique Gaudreault, Hugo Roméro, Corine Martineau, Olha Kevorkova, and Jaime Sanchez Dardon, “Alterations in Bone and Erythropoiesis in Hemolytic Anemia: Comparative Study in Bled, Phenylhydrazine-Treated and Plasmodium-Infected Mice,” PLoS ONE, vol. 7, no. 9, 2012. View at PublisherView at Google Scholar
  • Khaled M. Musallam, Ali T. Taher, and Eliezer A. Rachmilewitz, “beta-Thalassemia Intermedia: A Clinical Perspective,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 7, 2012. View at PublisherView at Google Scholar
  • Ceren Aksoy, Ali Guliyev, Emine Kilic, Duygu Uckan, and Feride Severcan, “Bone Marrow Mesenchymal Stem Cells in Patients with Beta Thalassemia Major: Molecular Analysis with Attenuated Total Reflection-Fourier Transform Infrared Spectroscopy Study as a Novel Method,” Stem Cells and Development, vol. 21, no. 11, pp. 2000–2011, 2012. View at PublisherView at Google Scholar
  • Paolo Ricchi, Massimiliano Ammirabile, Silvia Costantini, Tiziana Di Matola, Roberto Verna, Alvaro Diano, Maria Carmela Foglia, Anna Spasiano, Patrizia Cinque, and Luciano Prossomariti, “A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients with thalassemia intermedia: a prospective study,” Annals Of Hematology, vol. 91, no. 6, pp. 905–909, 2012. View at PublisherView at Google Scholar
  • E. Vlachaki, A. Kalogeridis, N. Neokleous, V. Perifanis, F. Klonizakis, E. Ioannidou, and I. Klonizakis, “Absence of JAK2V617F mutation in patients with beta-thalassemia major and thrombocytosis due to splenectomy,” Molecular Biology Reports, vol. 39, no. 5, pp. 6101–6105, 2012. View at PublisherView at Google Scholar
  • Stefano Rivella, “The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia,” Blood Reviews, vol. 26, pp. S12–S15, 2012. View at PublisherView at Google Scholar
  • Maria D. Cappellini, John C. Wood, Ali T. Taher, and Khaled M. Musallam, “Iron overload in non-transfusion-dependent thalassemia: a clinical perspective,” Blood Reviews, vol. 26, pp. S16–S19, 2012. View at PublisherView at Google Scholar
  • David M. Frazer, Sarah J. Wilkins, Deepak Darshan, Alison C. Badrick, Gordon D. McLaren, and Gregory J. Anderson, “Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression,” British Journal of Haematology, vol. 157, no. 5, pp. 615–626, 2012. View at PublisherView at Google Scholar
  • Duygu Uckan, Feride Severcan, and Ceren Aksoy, “FTIR spectroscopic imaging of mesenchymal stem cells in beta thalassemia major disease state,” Biomedical Spectroscopy and Imaging, vol. 1, no. 1, pp. 67–78, 2012. View at PublisherView at Google Scholar
  • Pedro Ramos, Carla Casu, Sara Gardenghi, Laura Breda, Bart J. Crielaard, Ella Guy, Maria Franca Marongiu, Ritama Gupta, Ross L. Levine, Omar Abdel-Wahab, Benjamin L. Ebert, Nico Van Rooijen, Saghi Ghaffari, Robert W. Grady, Patricia J. Giardina, and Stefano Rivella, “Macrophages support pathological erythropoiesis in polycythemia vera and beta-thalassemia,” Nature Medicine, vol. 19, no. 4, pp. 437–+, 2013. View at PublisherView at Google Scholar
  • Barbara Kaczorowska-Hac, Lucyna MacIejka-Kapuscinska, Ewa Milosz-Bartoszewicz, and Elzbieta Adamkiewicz-Drozynska, “Coexistence of β-thalassemia trait and hemochromatosis in a 5-year-old girl of Polish origin,” Journal of Pediatric Hematology/Oncology, vol. 35, no. 3, pp. 239–240, 2013. View at PublisherView at Google Scholar
  • Elliott Vichinsky, Eliezer A. Rachmilewitz, and Stefano Rivella, “Non-transfusion-dependent thalassemias,” Haematologica, vol. 98, no. 6, pp. 833–844, 2013. View at PublisherView at Google Scholar
  • Laura Breda, and Stefano Rivella, “Modulators of Erythropoiesis,” Hematology/Oncology Clinics of North America, 2014. View at PublisherView at Google Scholar
  • Fernando Oliveira, Sara Rocha, and Rúben Fernandes, “Iron Metabolism: From Health to Disease,” Journal of Clinical Laboratory Analysis, 2014. View at PublisherView at Google Scholar
  • S. Rivella, and B.J. Crielaard, “Disorders of Iron Metabolism: Iron Deficiency and Iron Overload and Anemia of Chronic Diseases,” Pathobiology of Human Disease, pp. 1471–1487, 2014. View at PublisherView at Google Scholar
  • Stefano Rivella, “beta-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies,” Haematologica, vol. 100, no. 4, pp. 421–433, 2015. View at PublisherView at Google Scholar
  • Rekha Athiyarath, Biju George, Aby Abraham, Auro Viswabandya, Alok Srivastava, and Eunice Sindhuvi Edison, “Genetic modifiers of secondary iron overload in beta thalassemia major,” Blood Cells, Molecules, and Diseases, 2015. View at PublisherView at Google Scholar
  • Surasak Wichaiyo, Paranee Yatmark, Ronald Enrique Morales Vargas, Pimtip Sanvarinda, Saovaros Svasti, Suthat Fucharoen, and Noppawan Phumala Morales, “Effect of Iron Overload on Furin Expression in Wild-type and β-Thalassemic Mice,” Toxicology Reports, 2015. View at PublisherView at Google Scholar
  • Somnath Mukherjee, Rashmi R. Das, and Babita Raghuwanshi, “Non-transfusion dependent thalassemias: A developing country perspective,” Current Pediatric Reviews, vol. 11, no. 2, pp. 87–97, 2015. View at PublisherView at Google Scholar
  • Antoine N. Saliba, and Ali T. Taher, “Morbidities in non-transfusion-dependent thalassemia,” Annals of the New York Academy of Sciences, vol. 1368, no. 1, pp. 82–94, 2016. View at PublisherView at Google Scholar
  • C. Casu, P. R. Oikonomidou, H. Chen, V. Nandi, Y. Ginzburg, P. Prasad, R. E. Fleming, Y. M. Shah, E. V. Valore, E. Nemeth, T. Ganz, B. MacDonald, and S. Rivella, “Minihepcidin peptides as disease modifiers in mice affected by  -thalassemia and polycythemia vera,” Blood, vol. 128, no. 2, pp. 265–276, 2016. View at PublisherView at Google Scholar
  • Abolhassan Ghaderi, Mohammad Reza Hafezi Ahmadi, Ehsan Hosseini, Ali Akbar Movasaghpour Akbari, Abbas Ali Hosein Pour Feyzi, Ataollah Hiradfar, and Majid Farshdousti Hagh, “Prevalence of the C282Y and H63D mutations of the HFE hemochromatosis gene in Azerian major β-thalassemia and iron overload,” Comparative Clinical Pathology, vol. 25, no. 1, pp. 151–154, 2016. View at PublisherView at Google Scholar
  • Ibrahim M. Badraia, Adel A. Hagag, Mohamed S. Elfarargy, and Amany M. Abo El-Enein, “Gonadal hormones in adolescent females with β-thalassemia in relation to Iron load,” Endocrine, Metabolic and Immune Disorders - Drug Targets, vol. 16, no. 2, pp. 148–153, 2016. View at PublisherView at Google Scholar
  • Mervat El-Sayed Mohamed, Samir Mostafa Abdel-Aziz, Amal Mahmmed Noureldin, Mohamed Ali El-Desouky, Eithar Karem El-Adham, and Noha Sayed Hamed, “Effect of iron overload and iron chelators on anti-müllerian hormone level in Egyptian female patients with transfusion-dependent Β-thalassemia,” Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 4, pp. 263–267, 2017. View at PublisherView at Google Scholar
  • Paraskevi Rea Oikonomidou, and Stefano Rivella, “What can we learn from ineffective erythropoiesis in thalassemia?,” Blood Reviews, 2017. View at PublisherView at Google Scholar
  • Niwansa Adris, Anita Chai Geik Chua, Matthew William Knuiman, Mark Laurence Divitini, Debbie Trinder, and John Kevin Olynyk, “A prospective cohort examination of haematological parameters in relation to cancer death and incidence: the Busselton Health Study,” BMC Cancer, vol. 18, no. 1, 2018. View at PublisherView at Google Scholar
  • Carla Casu, Elizabeta Nemeth, and Stefano Rivella, “Hepcidin agonists as therapeutic tools,” Blood, vol. 131, no. 16, pp. 1790–1794, 2018. View at PublisherView at Google Scholar
  • Maria Domenica Cappellini, John B. Porter, Vip Viprakasit, and Ali T. Taher, “A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?,” Blood Reviews, 2018. View at PublisherView at Google Scholar
  • Chingiz Asadov, Zohra Alimirzoeva, Tahira Mammadova, Gunay Aliyeva, Shahla Gafarova, and Jeyhun Mammadov, “β-Thalassemia intermedia: a comprehensive overview and novel approaches,” International Journal of Hematology, 2018. View at PublisherView at Google Scholar
  • Ali T. Taher, Elena Cassinerio, Stefano Rivella, Brian Gadbaw, Yesim Aydinok, Zeynep Karakas, Noppadol Siritanaratkul, Antonis Kattamis, Aurelio Maggio, Norbert Hollaender, and Bruyere Mahuzier, “Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study,” Blood, vol. 131, no. 2, pp. 263–265, 2018. View at PublisherView at Google Scholar
  • Joseph Sleiman, Ali Tarhini, Rayan Bou-Fakhredin, Antoine Saliba, Maria Cappellini, and Ali Taher, “Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management,” International Journal of Molecular Sciences, vol. 19, no. 1, pp. 182, 2018. View at PublisherView at Google Scholar
  • John Chapin, and Patricia J. Giardina, “Thalassemia Syndromes,” Hematology, pp. 546–570.e10, 2018. View at PublisherView at Google Scholar
  • Amal El-Beshlawy, and Mona El-Ghamrawy, “Recent trends in treatment of thalassemia,” Blood Cells, Molecules, and Diseases, 2019. View at PublisherView at Google Scholar
  • Antonio Piga, Silverio Perrotta, Maria Rita Gamberini, Ersi Voskaridou, Angela Melpignano, Aldo Filosa, Vincenzo Caruso, Antonello Pietrangelo, Filomena Longo, Immacolata Tartaglione, Caterina Borgna-Pignatti, Xiaosha Zhang, Abderrahmane Laadem, Matthew L. Sherman, and Kenneth M. Attie, “Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia,” Blood, vol. 133, no. 12, pp. 1279–1289, 2019. View at PublisherView at Google Scholar